“…Three studies were conducted in the Netherlands, 28,36,37 2 in Portugal, 33,35 2 in Belgium, 31,32 2 in the United States, 27,39 2 in Canada, 26,34 1 in Australia, 25 2 in the United Kingdom, 30,38 and 1 in Sweden. 29 The patient profile within the studies included patients with heart failure (mostly systolic dysfunction, NYHA [New York Heart Association] class II and III) with reduced or preserved ejection fraction, 29,30,37,38 those who had been diagnosed with coronary artery disease, ischemic heart disease, and/or acute coronary syndrome and who were treated for such including via coronary artery bypass grafting or revascularization surgery. 25-28,31-36,39…”